Our Studies

To date, we have successfully completed over 500 FDA-approved studies in the areas of allergy, asthma and immunological diseases. At any given time, we are running numerous studies, advancing the frontiers of research and the possibilities of treatments every day.

CURRENT STUDIES

To apply to participate in one of our studies, please go here. If you would like to participate in a specific study, please note that when you fill out our survey.

Alladapt – Multi Food OIT Study

Study Treatment: 15 food oral immunotherapy
Subjects: 4-55 years of age with food allergy

Regeneron – Registry of Asthma Patients Initiating Dupilumab

Subjects: 12 years of age and older with asthma

For full information go to this link in clinicaltrials.gov

AstraZeneca- Adult EGPA Study Study

Study Treatment: Study to Evaluate Benralizumab Compared to Mepolizumab
Subjects: 18 years or older with EGPA

For full information go to this link in clinicaltrials.gov

Takeda – Hereditary Angioedema Study

Real-world effectiveness of Lanadelumab
Subjects: HAE Type 1 or 2

For full information go to this link in clinicaltrials.gov

Interested in Participating in a Study?

GET INVOLVED

If you are eligible you will be contacted by one our research coordinators.

Regeneron – Adult Birch Allergy Study

Study Treatment: Anti-Bet v 1 Monoclonal Antibodies
Subjects: 18 years or older with birch pollen allergy

For full information go to this link in clinicaltrials.gov

ONGOING STUDIES
(NO FURTHER ENROLLMENT)

  • Aimmune AIME01

  • Aimmune Rollover ARC008

  • Biocryst – HAE Study
  • DBV EPITOPE/ EPOPEX
  • DBV MILES

  • DBV PEPITES/PEOPLE

  • DBV REALISE

  • Regeneron R668-ALG-16114
  • Regeneron R668-EE-1774
  • Astellas MATRIX II
  • UW Hallstrand Asthma Study